EWTX Overview

Company Profile

Related stocks

PBLS • United States

Parabilis Medicines, Inc.

27.48 USD

3.39B USD

MANE • United States

Veradermics, Incorporated

130.9 USD

5.47B USD

COGT • United States

Cogent Biosciences, Inc.

31 USD

5.38B USD 1Y +93.1%

DNTH • United States

Dianthus Therapeutics, Inc.

82.37 USD

4.5B USD 1Y +137.2%

TARS • United States

Tarsus Pharmaceuticals, Inc.

73.16 USD

3.42B USD 1Y +3.5%

ELVN • United States

Enliven Therapeutics, Inc.

40.98 USD

3B USD 1Y +100%

CGON • United States

CG Oncology, Inc.

63.82 USD

5.66B USD 1Y +55.4%

PTCT • United States

PTC Therapeutics, Inc.

64.7 USD

5.4B USD 1Y -3%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile

4 Metrics

Country

Region

Sector

Industry

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High

5Y Volatility

80.6% p.a.

Max Drawdown (5Y)

-75.4%

Sharpe Ratio (5Y)

0.17

Beta Factor

0.35

Size Class

Mid Cap

Notes & Warnings

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Exemplary balance sheet strength: Very solid ratio of equity to debt.

Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (80.6% p.a.).

Historical Stress Test: Maximum peak-to-trough drawdown of -75.4% in the extended horizon.